Skip to content

Study on the key technology and clinical application of accelerated rehabilitation of joint surgery by combining traditional Chinese and western medicine based on the formula of Huayu-Xiaozhong-Fang

Study on the key technology and clinical application of accelerated rehabilitation of joint surgery by combining traditional Chinese and western medicine based on the formula of Huayu-Xiaozhong-Fang

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082820
Enrollment
Unknown
Registered
2024-04-09
Start date
2023-07-21
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee/Hip Arthroplasty

Interventions

Control group:Standard treatment: ice packs, dynamic monitoring, placement of intravenous pumps (twice a day for 7 days), rehydration, rehydration and supportive therapy from the time of return to the
Treament group:On the basis of the control group, one dose of the formula for resolving blood stasis and eliminating swelling (12g of peach kernel, 9g of safflower, 9g of Angelica sinensis, 9g of Radi

Sponsors

Liaocheng City Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of osteonecrosis of the femoral head, fracture of the femoral neck, osteoarthritis of the knee, and intend to have hip and knee joint replacement; ? Age 65~80 years old, able to communicate and cooperate with the treatment; ? Preoperative blood indexes, normal coagulation function and no history of lower extremity venous thrombosis; ?Preoperative assessment of no major underlying diseases or those with but no contraindications to surgery; ? Patients who are informed and willing to accept the test and sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? Do not meet the above inclusion criteria; ? Those who are assessed to have serious heart, lung, liver, kidney, brain and blood system diseases, etc., and cannot tolerate the surgery; ? Those who are taking aspirin, clopidogrel, ticlopidine and other drugs; Those who refuse to participate in the trial and those who are confused or uncooperative so that the efficacy of the treatment cannot be assessed accurately; Those who have serious complications or allergic reactions during the trial and have to terminate the trial. Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

MeasureTime frame
Blood indicators;Hip/knee function;deep vein thrombosis;

Secondary

MeasureTime frame
General information;Pain;degree of swelling;

Countries

China

Contacts

Public ContactDongwei Wang

Liaocheng City Hospital of Traditional Chinese Medicine

13863550843@163.com+86 177 6353 1766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026